Colchicine + Febuxostat + SHR4640
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedAbout Colchicine + Febuxostat + SHR4640
Colchicine + Febuxostat + SHR4640 is a phase 1 stage product being developed by Jiangsu Hengrui Medicine for Gout. The current trial status is completed. This product is registered under clinical trial identifier NCT03131583. Target conditions include Gout.
What happened to similar drugs?
7 of 20 similar drugs in Gout were approved
Approved (7) Terminated (3) Active (11)
🔄SHR4640 dose1 + SHR4640 dose2 + Placebo oral tablet + Allopurinol 300 MGJiangsu Hengrui MedicinePhase 3
🔄HR091506 tablets + placebo of febuxostat tablets + febuxostat tablets + placebo of HR091506 tabletsJiangsu Hengrui MedicinePhase 3
🔄HR091506 tablets + placebo of febuxostat tablets + febuxostat tablets + placebo of HR091506 tabletsJiangsu Hengrui MedicinePhase 3
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03131583 | Phase 1 | Completed |
Competing Products
20 competing products in Gout